Tag: Heart Bypass
Improved Outcomes With Public Reporting of CABG Data
Decrease in observed and expected mortality rates, risk factor rates from 2002 to 2014 in Massachusetts
Lower Thromboembolic Risk With New A-Fib After CABG Versus NVAF
Thromboembolic risk lower for postoperative atrial fibrillation s/p CABG versus nonvalvular a-fib
Anticoagulation Guidance Issued for Cardiopulmonary Bypass
Recommendations for heparin dosing and monitoring, contraindications and alternatives, reversal
CABG May Be Best Method to Revascularize in Diabetes
Cardiac, cerebrovascular events lower in patients with multivessel coronary artery disease
CABG May Be Best for Multivessel Revascularization in T1DM
Increased risks of coronary heart disease mortality, MI, repeat revascularization with PCI
On-Pump CABG Leads to Higher Rates of Five-Year Survival
Study compared coronary-artery bypass grafting surgery, with/without cardiopulmonary bypass
Multiple Dosing Mitigates ASA Hyporesponsiveness After CABG
Multiple dosing more effective than ASA 81 or 325 mg once-daily for suppressing serum TXB2 formation
Continuing Statins Up to Surgery May Improve CABG Outcomes
Continuing medications up to and on operation day linked to better survival rates in study
Anaortic Off-Pump CABG Tied to Reduced Risk of Post-Op Stroke
AnOPCABG linked to reduced risk of mortality, renal failure, bleeding complications, atrial fibrillation
Better Teamwork Linked to Improved Outcomes for CABG
Health systems with higher teamwork levels have lower 60-day rates of ER visits, readmission, death
